Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Most recent
Best match
Santé log
5m
Oncocyte’s DetermaIO Immuno-Oncology Assay Predicts Response to Atezolizumab in Phase 2 Clinical Trial
Among PD-L1 IHC, sTILs and 11 immune signatures analyzed, only DetermaIO was significant for interaction, meaning it could predict which patients were most likely to achieve pathologic complete ...
Targeted Oncology
20m
SunRISe-2 Study of TAR-200 Plus Cetrelimab in MIBC Discontinues
The SunRISe-2 trial evaluating TAR-200 combined with cetrelimab vs chemoradiation in muscle-invasive bladder cancer has been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Human life expectancy study
To campaign for Harris
More troops to Ukraine?
First deputy mayor resigns
Florida orders evacuations
Jets fire head coach Saleh
Medical copter crash kills 3
Kemp suspends GA mayor
Sex abuse case dismissed
Richest female musician
To replace lead water pipes
Rwandan virus screening
Athlete payments approval
Tickets to climb to $5
Hamas backers sanctioned
Israel expands offensive
Harris on '60 Minutes'
Hears ghost gun rule case
Settles latest civil lawsuit
States sue TikTok
US overdose deaths drop
Liquidation plan approved
Win Nobel Prize in physics
Ordered to open app store
Targeted by a cyberattack
Former aide charged
North Dakota wildfires
Hera mission launched
SCOTUS denies appeal
Intel defensive briefings rise
Feedback